参考文献/References:
1 Chung JK,Kim YK,Kim SK,et al.Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isonietabolic on 18F-FDG PET.Eur J Nucl Med Mol Imaging,2002,29(2):176-182.
2 Langen KJ,Muhlensiepen H,Holschbach M,et al.Transport mechanisms of 3-[123]iodo-α-methvl-L-tyrosine in a human glioma cell line:comparison with [3H-methy]]-L-methionine.J Nucl Med,2000,41(7):1250-1255.
3 Kracht LW,Friese M,Herholz K.et al.Methyl-[11C]-L-rnethionine uptake as measured by positron emission tomography correlates to microvessel density in patienls with glioma.Eur J Nucl Med Mol Imaging,2003,30(6):868-873.
4 Giammarile F,Cinotti LE,Jouvet A,et al.High and low grade oligodendrogliomas (ODG):correlation of amino-acid and glucose uptakes using PET and histological classifications.J Neurooncol,2004,68(3):263-274.
5 Sunada I,Tsuyuguchi N,Hara M,et al.18F-FDG and 11C-methionine PET in choroid plexus papilloma-report of three cases.Radiat Med,2002,20(2):97-100.
6 Rau FC,Weber WA,Wester HJ,et al.O-(2-[18F]Fluoroethyl)-L-tyrosine (FET):a tracer for differentiation of tumour from inflammation in murine lymph nodes.Eur J Nucl Med Mol Imaging,2002,29(8):1039-1046.
7 Kaim AH,Weber B,Kurrer MO,et al.18F-FDC and 18F-FET uptake in experimental soft tissue infection.Eur J Nucl Med Mol Imaging,2002,29(5):648-654.
8 Weber WA,Wester HJ,Grosu AL,et a l.O-(2-[18FJFluoroethyl)-L-tyrosine and L-[methyl-11C] methionine uptake in brain tumours:initial results of a comparative study.Eur J Nucl Med Mol Imaging,2000,27(5):542-549.
9 Floeth FW,Pauleit D,Wittsack HJ,et al.Multimodal metabolic imaging of cerebral gliomas:positron emission tomography with [18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.J Neurosurg,2005,102(2):318-327.
10 Pauleit D,Stoffels G,Schaden W,et al.PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors:first clinical results.J Nucl Med,2005,46(3):411-416.
11 Ohtani T,Kurihara H,Ishiachi S,et al.Brain tumour imaging with carbon-11 choline:comparison with FDG PET and gadolinium-enhanced MR imaging.EurJ Nucl Med Mol Imaging,2001,28(11):1664-1670
12 Kwee SA,Coel MN,Lim J,et al.Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.J Neuroimaging,2004,14(3):285-289.
13 Tian M,Zhang H,Oriuchi N,et al.Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.Eur J Nucl Med Mol Imaging,2004,31(8):1064-1072.
14 Zhang H,Tian M,Oriuchi N,et al.11C-choiine PET for the detection of bone and soft tissue tumours in comparison with FDG PET.Nucl Med Commun,2003,24(3):273-279.
15 Toyohara J,Waki A,Takamatsu S,et al.Basis of FLT as a cell proliferation marker:comparative uptake studies with [3H]thymidine and [3H]arabinothymidine,and cell-analysis in 22 asynchronously growing tumor cell line.Nucl Med Biol,2002,29(3):281-287.
16 Rasey JS,Grierson JR,Wiens LW,et al.Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.J Nucl Med,2002,43(9):1210-1217.
17 Chen W,Cloughesy T,Kamdar N,et al.Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG.J Nucl Med,2005,46(6):945-952.
18 Jacobs AH,Thomas A,Kracht LW,et al.18F-fluoro-L-tKymidine and 11C methylmethionine as markers of increased transport and proliferation in brain tumors.J Nucl Med,2005,46(12):1948-1958.
19 Pirotte B,Goldman S,Massager N,et al.Combined use of 18F-fluorodeoxyglucose and 11C methionine in 45 positron emission tomography-guided stereotactic brain biopsies.J Neurosurg,2004,101(3):476-483.
20 Pirotte B,Goldman S,Massager N,et al.Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.J Nucl Med,2004,45(8); 1293-1298.
21 Grosu AL,Weber WA,Franz M,et al.Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.Int J Radiat Oncol Biol Phys,2005,63(2):511-519.
22 Ribom D,Engler H,Blomquist E,et al.Potential significance of (11) C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.Eur J Nucl Med Mol Imaging,2002,29(5):632-640.
23 Kim S,Chung JK,Im SH,et al.11C-methionine PET as a prognostic marker in patients with glioma:comparison with 18F-FDG PET.Eur J Nucl Med Mol Imaging,2005,32(1):52-59.
24 Van Laere K,Ceyssens S,Van Calenbergh F,et al.Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma:sensitivity,inter-observer variability and prognostic value.Eur J Nucl Med Mol Imaging,2005,32(1):39-51.
25 Rachinger W,Goetz C,Popperl G,et a l.Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.Neurosurgery,2005,57(3):505-511
26 Chen W,Cloughesy T,Kamdar N,et al.Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG.J Nucl Med,2005,46(6):945-952.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[12]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[13]陶绪长,罗晓文,关晏星.阿德福韦酯所致低血磷性骨软化症治疗前后SPECT骨显像对比一例[J].国际放射医学核医学杂志,2015,39(6):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[14]成钊汀,朱小华.99Tcm-MIBI显像在甲状旁腺功能亢进症中的应用及进展[J].国际放射医学核医学杂志,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
Cheng Zhaoting,Zhu Xiaohua.Application and progress of 99Tcm-MIBI scintieraphy in parathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
[15]林潇,唐明灯.靶向表皮生长因子受体分子探针研究进展[J].国际放射医学核医学杂志,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
Lin Xiao,Tang Mingdeng.Research progresses on molecular probes targeting epidermal growth factor receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
[16]刘晓梅,张芳,黄建敏.肿瘤血管生成的SPECT分子显像研究进展[J].国际放射医学核医学杂志,2015,39(2):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
Liu Xiaomei,Zhang Fang,Huang Jianmin.Research advance on molecular imaging of tumor angiogenesis with SPECT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
[17]刘晋华,张宝牛,赵德善.盆腔融合异位肾一例[J].国际放射医学核医学杂志,2015,39(2):190.[doi:10.3760/cma.j.issn.1673-4114.2015.02.020]
[18]陈明,刘纯,严祥,等.SPECT胃黏膜显像在胃中间横带研究中的价值[J].国际放射医学核医学杂志,2015,39(3):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
Chen Ming,Liu Chun,Yan Xiang,et al.The value of gastric mucosa SPECT in the study of midgastric transverse band[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
[19]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[20]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]